Are you over 18 and want to see adult content?
More Annotations
![A complete backup of beautifulagony.com](https://www.archivebay.com/archive5/images/f85fdfa5-960a-4a8f-a491-c1367ea3fe73.png)
A complete backup of beautifulagony.com
Are you over 18 and want to see adult content?
![A complete backup of www.www.imagefap.com](https://www.archivebay.com/archive5/images/d10aea4f-7753-4bdc-bd3f-994f1af4d657.png)
A complete backup of www.www.imagefap.com
Are you over 18 and want to see adult content?
![A complete backup of www.www.yournnpic.com](https://www.archivebay.com/archive5/images/fe595d0d-ff47-42ff-ac4b-b830c46d4145.png)
A complete backup of www.www.yournnpic.com
Are you over 18 and want to see adult content?
![A complete backup of www.xhamster.desi](https://www.archivebay.com/archive5/images/c37dc3f1-6aa2-49a3-aea8-b9317312e59f.png)
A complete backup of www.xhamster.desi
Are you over 18 and want to see adult content?
![A complete backup of amateuralbum.net](https://www.archivebay.com/archive5/images/1bdb0227-cfb6-4592-94f4-f0225ea8a54a.png)
A complete backup of amateuralbum.net
Are you over 18 and want to see adult content?
![A complete backup of thefappening.pro](https://www.archivebay.com/archive5/images/d160aa7f-7222-43e3-82ff-6dd22a9dc424.png)
A complete backup of thefappening.pro
Are you over 18 and want to see adult content?
![A complete backup of www.nerdpervert.com](https://www.archivebay.com/archive5/images/f211a03e-f926-4901-83e0-56dc4a050455.png)
A complete backup of www.nerdpervert.com
Are you over 18 and want to see adult content?
![A complete backup of www.nakenprat.com](https://www.archivebay.com/archive5/images/4f6c9e57-b35f-4d06-b1cd-83eb3cc198f5.png)
A complete backup of www.nakenprat.com
Are you over 18 and want to see adult content?
![A complete backup of www.www.zenra.net](https://www.archivebay.com/archive5/images/4e419f4d-ea94-4902-bcc6-d16d9321c7ab.png)
A complete backup of www.www.zenra.net
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of dewiphelix.blogspot.com](https://www.archivebay.com/archive/74d0f729-db15-4015-9c67-68a07f936479.png)
A complete backup of dewiphelix.blogspot.com
Are you over 18 and want to see adult content?
![A complete backup of strategiadegliscacchi.wordpress.com](https://www.archivebay.com/archive/c2ac76d0-811c-4bee-b446-8fc32ae0b159.png)
A complete backup of strategiadegliscacchi.wordpress.com
Are you over 18 and want to see adult content?
![A complete backup of propertycontinental.com](https://www.archivebay.com/archive/7c385aaf-0317-412d-86d6-de4561c1df77.png)
A complete backup of propertycontinental.com
Are you over 18 and want to see adult content?
![A complete backup of pcgamingwiki.com](https://www.archivebay.com/archive/d7d322b5-45f0-4529-b3b9-3dcacce4fa3b.png)
A complete backup of pcgamingwiki.com
Are you over 18 and want to see adult content?
Text
patients.
IOL ADVANCES
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S.IOL
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S. OPHTHALMOLOGY TIMES: MARCH 1, 2021 New option may prove to be a solution for cataract cases with unusualcorneas.
GLAUCOMA - OPHTHALMOLOGY TIMES Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, offers an update on optimization and surgical modifications of newer glaucoma surgeries in preop and postop settings. CATARACT THERAPEUTICS A recent study may indicate the need for future research to assess the relationship between pain and the anterior chamber depth. PHILLIP H. PHAN, PHD During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of theeye
OPHTHALMOLOGY TIMES EUROPE In a presentation at ARVO, Friederike Kortuem, MD, MSc, explains that treatment with voretigene neparvovec-rzyl led to a short-term change in the foveal morphology in a patient with visual impairment that included nyctalopia and decreased visual acuity in early childhood. MONITORING BLOOD REFLUX DURING GONIOSCOPY IN GLAUCOMA Gonioscopy may offer a reasonable and cost-effective method to evaluate the function of the trabecular micro-bypass device post-implantation and it OPHTHALMOLOGY TIMESSPOTLIGHTCLINICALNEWSMEDIABUSINESSCONFERENCES More Americans have used and continue to use teleheath for mental health care. according to a recent online poll by the American Psychological Association. OPHTHALMOLOGY TIMES: MAY 2021 Study results show the device offers an effective long-term option forpatients.
IOL ADVANCES
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S.IOL
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S. OPHTHALMOLOGY TIMES: MARCH 1, 2021 New option may prove to be a solution for cataract cases with unusualcorneas.
GLAUCOMA - OPHTHALMOLOGY TIMES Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, offers an update on optimization and surgical modifications of newer glaucoma surgeries in preop and postop settings. CATARACT THERAPEUTICS A recent study may indicate the need for future research to assess the relationship between pain and the anterior chamber depth. PHILLIP H. PHAN, PHD During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of theeye
OPHTHALMOLOGY TIMES EUROPE In a presentation at ARVO, Friederike Kortuem, MD, MSc, explains that treatment with voretigene neparvovec-rzyl led to a short-term change in the foveal morphology in a patient with visual impairment that included nyctalopia and decreased visual acuity in early childhood. MONITORING BLOOD REFLUX DURING GONIOSCOPY IN GLAUCOMA Gonioscopy may offer a reasonable and cost-effective method to evaluate the function of the trabecular micro-bypass device post-implantation and it INSIGHTS - OPHTHALMOLOGY TIMES © 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
IOL
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S.DIGITAL EDITION
© 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
IOL ADVANCES
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S. TECHNOLOGY - OPHTHALMOLOGY TIMES Mohamed Abou Shousha, MD, PhD, and Richard Parrish II, MD, discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented realitydevices.
OCT - OPHTHALMOLOGY TIMES Daniel F. Kiernan, MD, discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery. GLAUCOMA - OPHTHALMOLOGY TIMES Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, offers an update on optimization and surgical modifications of newer glaucoma surgeries in preop and postop settings. 2019 OPHTHALMOLOGY TIMES RESEARCH SCHOLAR HONOREE PROGRAM Neesurg Mehta, MD Resident New York Eye and Ear Infirmary of Mount Sinai New York, NY . Chirag M. Shah, MD, MPH Resident University of California, Irvine Irvine, CA . Guneet Singh Sodhi, MD Resident Eastern Virginia Medical School Norfolk, VA . Matthew Starr, MD Residency Graduate Mayo Clinic Rochester, MN First Year Vitreoretinal Fellow Mid Atlantic Retina Wills Eye Hospital Philadelphia, PA PHAKIC IOLS: THE RIGHT FIT? "Phakic IOLs play an important role in managing higher ametropias, can be additive to other types of refractive surgery already being offered, and the implantation technique is very learnable for practitioners already doing intraocular surgery," said Dr Hardten, adjunct associate professor of ophthalmology, University of Minnesota, and director, refractive surgery, Minnesota Eye Consultants EXTENDED DEPTH-OF-FIELD IOLS: CLARIFICATION OF CURRENT Clinicians and surgeons should be aware of the misleading use of the EDOF concept. The authors herein propose an alternative terminology and that lenses which have combined optical designs are referred to asâhybrid IOLsâ.
OPHTHALMOLOGY TIMESSPOTLIGHTCLINICALNEWSMEDIABUSINESSCONFERENCES May 27, 2021. Upsher-Smith Laboratories LLC and Rafarm SA have announced the U.S. commercial launch of moxifloxacin ophthalmic solution, USP 0.5% following a recent abbreviated new drug application (ANDA) approval by the FDA. Outlook Therapeutics moving toward FDA approval of bevacizumab-vikg for treatment of wet AMD. May 27, 2021. OPHTHALMOLOGY TIMES: MAY 2021 ophthalmology-times-may-2021. New options are on horizon for presbyopia-correcting drops. May 31, 2021. Article. Therapeutic choices beneficial for patients may be available in 1 to 3 years. Big Brother is watching: Technology is looking out for me. May 30, 2021.IOL
Curvature-changing IOL: New frontier in cataract and presbyopia surgeries. April 10, 2021. Lens offers full range of vision from distance through near vision. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. OPHTHALMOLOGY TIMES: MARCH 1, 2021 ophthalmology-times-march-1-2021. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. Article. New option may prove to be a solution for cataract cases with unusual corneas. Raising the retinal disease treatment bar with genetic testing. April07, 2021. Article.
IOL ADVANCES
April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. Making sutureless double-needle scleral IOL fixation technique more accessible. March 13, 2021. Practice and preparation are key for mastering the procedure. Early clinical experience with next-generation lens. March 12, 2021. One surgeonshares the
DIGITAL EDITION
© 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
CATARACT THERAPEUTICS cataract-therapeutics. Benefits of topography-guided treatments for irregular corneas. June 01, 2021. Procedure can improve best-corrected visual acuity, enhancing quality of life for patients. Earlier neurolept anesthesia for laser-assisted cataract surgery: Timing may not be everything. May 20, 2021. A recent study may indicate the needfor
PHILLIP H. PHAN, PHD Phillip H. Phan, PhD. home. authors. phillip-h.-phan,-phd. Articles. Clearing hurdles to large scale telemedicine adoption. July 23, 2020. During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of theeye.
OPHTHALMOLOGY TIMES EUROPE Measuring visual fields with cloud-based AI platform. May 07, 2021. Dr Mohamed Abou Shousha and Dr Richard Parrish II discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented reality devices. CONTROVERSIES IN OPHTHALMOLOGY The full scientific programme for the March Congress is now available. OPHTHALMOLOGY TIMESSPOTLIGHTCLINICALNEWSMEDIABUSINESSCONFERENCES May 27, 2021. Upsher-Smith Laboratories LLC and Rafarm SA have announced the U.S. commercial launch of moxifloxacin ophthalmic solution, USP 0.5% following a recent abbreviated new drug application (ANDA) approval by the FDA. Outlook Therapeutics moving toward FDA approval of bevacizumab-vikg for treatment of wet AMD. May 27, 2021. OPHTHALMOLOGY TIMES: MAY 2021 ophthalmology-times-may-2021. New options are on horizon for presbyopia-correcting drops. May 31, 2021. Article. Therapeutic choices beneficial for patients may be available in 1 to 3 years. Big Brother is watching: Technology is looking out for me. May 30, 2021.IOL
Curvature-changing IOL: New frontier in cataract and presbyopia surgeries. April 10, 2021. Lens offers full range of vision from distance through near vision. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. OPHTHALMOLOGY TIMES: MARCH 1, 2021 ophthalmology-times-march-1-2021. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. Article. New option may prove to be a solution for cataract cases with unusual corneas. Raising the retinal disease treatment bar with genetic testing. April07, 2021. Article.
IOL ADVANCES
April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. Making sutureless double-needle scleral IOL fixation technique more accessible. March 13, 2021. Practice and preparation are key for mastering the procedure. Early clinical experience with next-generation lens. March 12, 2021. One surgeonshares the
DIGITAL EDITION
© 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
CATARACT THERAPEUTICS cataract-therapeutics. Benefits of topography-guided treatments for irregular corneas. June 01, 2021. Procedure can improve best-corrected visual acuity, enhancing quality of life for patients. Earlier neurolept anesthesia for laser-assisted cataract surgery: Timing may not be everything. May 20, 2021. A recent study may indicate the needfor
PHILLIP H. PHAN, PHD Phillip H. Phan, PhD. home. authors. phillip-h.-phan,-phd. Articles. Clearing hurdles to large scale telemedicine adoption. July 23, 2020. During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of theeye.
OPHTHALMOLOGY TIMES EUROPE Measuring visual fields with cloud-based AI platform. May 07, 2021. Dr Mohamed Abou Shousha and Dr Richard Parrish II discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented reality devices. CONTROVERSIES IN OPHTHALMOLOGY The full scientific programme for the March Congress is now available.IOL ADVANCES
April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. Making sutureless double-needle scleral IOL fixation technique more accessible. March 13, 2021. Practice and preparation are key for mastering the procedure. Early clinical experience with next-generation lens. March 12, 2021. One surgeonshares the
TECHNOLOGY - OPHTHALMOLOGY TIMES Technology helps physicians understand normal and abnormal macular anatomy. IOLs offer great vision, low risk profile for myopia. March 09, 2021. Phakic option provides hope to patients who are not candidates for laser vision correction. A menu of glaucomaDIGITAL EDITION
© 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
REFRACTIVE - OPHTHALMOLOGY TIMES Refractive surgery for treating myopia is linked to low rates of regression, enhancement. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. Tips to chart a course for safe, effective refractive surgery. March 25, 2021. GLAUCOMA - OPHTHALMOLOGY TIMES Eliminating the potential land mines in glaucoma surgery. May 05, 2021. Ophthalmologist details his preferred technique to avoid complications during procedure. Advantages of incorporating ECP into the surgeonâs armamentarium. May 05, 2021. Short learning curve, significant clinical advantages make this a comfortable addition. USING PIVOTAL STUDY DATA TO GUIDE GLAUCOMA PATIENT Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients. YAG-SHOTS IN IOLS: SAFE OR DANGEROUS? Poorly focused YAG shots lead irrevocably to a permanent defect in the IOL material and thus to possible effects on the quality of vision with straylight or glare. In a recent study, the differing amounts of damage that Nd:YAG causes in a range of hydrophilic and MINIMISING RISKS DURING ROUTINE OPHTHALMIC EXAMINATIONS IN This article will evaluate the risks surrounding the most commonly performed procedures during an ophthalmic exam, focusing particularly on procedures requiring contact with the eye, such as tonometry. Given that the COVID-19 pandemic involves a new virus, which has spread and behaved unpredictably, our understanding of patient management in JOHNSON + JOHNSON'S TECNIS EYHANCE TORIC II IOL LAUNCHES According to the company, more than 400 eyes of patients from 12 European countries have been fitted with the TECNIS Eyhance Toric II IOL, with surgeons surveyed noting that their patients are pleasedwith the results.
BROLUCIZUMAB FOR NEOVASCULAR AMD: SAFETY GUIDANCE AND Brolucizumab for neovascular AMD: Safety guidance and clinician perspectives. Although the majority of patients experience benefit with brolucizumab for the treatment of nAMD without severe adverse events, the risk of retinal vasculitis and/or retinal vascular occlusion needs to be balanced with potential benefits. OPHTHALMOLOGY TIMESSPOTLIGHTCLINICALNEWSMEDIABUSINESSCONFERENCES May 27, 2021. Upsher-Smith Laboratories LLC and Rafarm SA have announced the U.S. commercial launch of moxifloxacin ophthalmic solution, USP 0.5% following a recent abbreviated new drug application (ANDA) approval by the FDA. Outlook Therapeutics moving toward FDA approval of bevacizumab-vikg for treatment of wet AMD. May 27, 2021. OPHTHALMOLOGY TIMES: MAY 2021 ophthalmology-times-may-2021. New options are on horizon for presbyopia-correcting drops. May 31, 2021. Article. Therapeutic choices beneficial for patients may be available in 1 to 3 years. Big Brother is watching: Technology is looking out for me. May 30, 2021.IOL
Curvature-changing IOL: New frontier in cataract and presbyopia surgeries. April 10, 2021. Lens offers full range of vision from distance through near vision. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. OPHTHALMOLOGY TIMES: MARCH 1, 2021 ophthalmology-times-march-1-2021. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. Article. New option may prove to be a solution for cataract cases with unusual corneas. Raising the retinal disease treatment bar with genetic testing. April07, 2021. Article.
IOL ADVANCES
April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. Making sutureless double-needle scleral IOL fixation technique more accessible. March 13, 2021. Practice and preparation are key for mastering the procedure. Early clinical experience with next-generation lens. March 12, 2021. One surgeonshares the
DIGITAL EDITION
© 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
CATARACT THERAPEUTICS cataract-therapeutics. Benefits of topography-guided treatments for irregular corneas. June 01, 2021. Procedure can improve best-corrected visual acuity, enhancing quality of life for patients. Earlier neurolept anesthesia for laser-assisted cataract surgery: Timing may not be everything. May 20, 2021. A recent study may indicate the needfor
PHILLIP H. PHAN, PHD Phillip H. Phan, PhD. home. authors. phillip-h.-phan,-phd. Articles. Clearing hurdles to large scale telemedicine adoption. July 23, 2020. During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of theeye.
OPHTHALMOLOGY TIMES EUROPE Measuring visual fields with cloud-based AI platform. May 07, 2021. Dr Mohamed Abou Shousha and Dr Richard Parrish II discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented reality devices. CONTROVERSIES IN OPHTHALMOLOGY The full scientific programme for the March Congress is now available. OPHTHALMOLOGY TIMESSPOTLIGHTCLINICALNEWSMEDIABUSINESSCONFERENCES May 27, 2021. Upsher-Smith Laboratories LLC and Rafarm SA have announced the U.S. commercial launch of moxifloxacin ophthalmic solution, USP 0.5% following a recent abbreviated new drug application (ANDA) approval by the FDA. Outlook Therapeutics moving toward FDA approval of bevacizumab-vikg for treatment of wet AMD. May 27, 2021. OPHTHALMOLOGY TIMES: MAY 2021 ophthalmology-times-may-2021. New options are on horizon for presbyopia-correcting drops. May 31, 2021. Article. Therapeutic choices beneficial for patients may be available in 1 to 3 years. Big Brother is watching: Technology is looking out for me. May 30, 2021.IOL
Curvature-changing IOL: New frontier in cataract and presbyopia surgeries. April 10, 2021. Lens offers full range of vision from distance through near vision. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. OPHTHALMOLOGY TIMES: MARCH 1, 2021 ophthalmology-times-march-1-2021. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. Article. New option may prove to be a solution for cataract cases with unusual corneas. Raising the retinal disease treatment bar with genetic testing. April07, 2021. Article.
IOL ADVANCES
April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. Making sutureless double-needle scleral IOL fixation technique more accessible. March 13, 2021. Practice and preparation are key for mastering the procedure. Early clinical experience with next-generation lens. March 12, 2021. One surgeonshares the
DIGITAL EDITION
© 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
CATARACT THERAPEUTICS cataract-therapeutics. Benefits of topography-guided treatments for irregular corneas. June 01, 2021. Procedure can improve best-corrected visual acuity, enhancing quality of life for patients. Earlier neurolept anesthesia for laser-assisted cataract surgery: Timing may not be everything. May 20, 2021. A recent study may indicate the needfor
PHILLIP H. PHAN, PHD Phillip H. Phan, PhD. home. authors. phillip-h.-phan,-phd. Articles. Clearing hurdles to large scale telemedicine adoption. July 23, 2020. During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of theeye.
OPHTHALMOLOGY TIMES EUROPE Measuring visual fields with cloud-based AI platform. May 07, 2021. Dr Mohamed Abou Shousha and Dr Richard Parrish II discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented reality devices. CONTROVERSIES IN OPHTHALMOLOGY The full scientific programme for the March Congress is now available.IOL ADVANCES
April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. Making sutureless double-needle scleral IOL fixation technique more accessible. March 13, 2021. Practice and preparation are key for mastering the procedure. Early clinical experience with next-generation lens. March 12, 2021. One surgeonshares the
TECHNOLOGY - OPHTHALMOLOGY TIMES Technology helps physicians understand normal and abnormal macular anatomy. IOLs offer great vision, low risk profile for myopia. March 09, 2021. Phakic option provides hope to patients who are not candidates for laser vision correction. A menu of glaucomaDIGITAL EDITION
© 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
REFRACTIVE - OPHTHALMOLOGY TIMES Refractive surgery for treating myopia is linked to low rates of regression, enhancement. Light-adjustable IOL offers positive refractive results in patients. April 08, 2021. New option may prove to be a solution for cataract cases with unusual corneas. Tips to chart a course for safe, effective refractive surgery. March 25, 2021. GLAUCOMA - OPHTHALMOLOGY TIMES Eliminating the potential land mines in glaucoma surgery. May 05, 2021. Ophthalmologist details his preferred technique to avoid complications during procedure. Advantages of incorporating ECP into the surgeonâs armamentarium. May 05, 2021. Short learning curve, significant clinical advantages make this a comfortable addition. USING PIVOTAL STUDY DATA TO GUIDE GLAUCOMA PATIENT Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients. YAG-SHOTS IN IOLS: SAFE OR DANGEROUS? Poorly focused YAG shots lead irrevocably to a permanent defect in the IOL material and thus to possible effects on the quality of vision with straylight or glare. In a recent study, the differing amounts of damage that Nd:YAG causes in a range of hydrophilic and MINIMISING RISKS DURING ROUTINE OPHTHALMIC EXAMINATIONS IN This article will evaluate the risks surrounding the most commonly performed procedures during an ophthalmic exam, focusing particularly on procedures requiring contact with the eye, such as tonometry. Given that the COVID-19 pandemic involves a new virus, which has spread and behaved unpredictably, our understanding of patient management in JOHNSON + JOHNSON'S TECNIS EYHANCE TORIC II IOL LAUNCHES According to the company, more than 400 eyes of patients from 12 European countries have been fitted with the TECNIS Eyhance Toric II IOL, with surgeons surveyed noting that their patients are pleasedwith the results.
BROLUCIZUMAB FOR NEOVASCULAR AMD: SAFETY GUIDANCE AND Brolucizumab for neovascular AMD: Safety guidance and clinician perspectives. Although the majority of patients experience benefit with brolucizumab for the treatment of nAMD without severe adverse events, the risk of retinal vasculitis and/or retinal vascular occlusion needs to be balanced with potential benefits. OPHTHALMOLOGY TIMESSPOTLIGHTCLINICALNEWSMEDIABUSINESSCONFERENCES More Americans have used and continue to use teleheath for mental health care. according to a recent online poll by the American Psychological Association.IOL
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S. TECHNOLOGY - OPHTHALMOLOGY TIMES Mohamed Abou Shousha, MD, PhD, and Richard Parrish II, MD, discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented realitydevices.
OPHTHALMOLOGY TIMES: MAY 2021 Short learning curve, significant clinical advantages make this a comfortable addition. OPHTHALMOLOGY TIMES: MARCH 1, 2021 New option may prove to be a solution for cataract cases with unusualcorneas.
CATARACT THERAPEUTICS A recent study may indicate the need for future research to assess the relationship between pain and the anterior chamber depth. PHILLIP H. PHAN, PHD During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of theeye
MONITORING BLOOD REFLUX DURING GONIOSCOPY IN GLAUCOMAGONIOSCOPY ANGLEGONIOSCOPY EXAMGONIOSCOPY GRADING SYSTEMSGONIOSCOPY IMAGESGONIOSCOPY PROCEDURE 92020OVERUSE OF GONIOSCOPY Gonioscopy may offer a reasonable and cost-effective method to evaluate the function of the trabecular micro-bypass device post-implantation and it OPHTHALMOLOGY TIMES EUROPEOPHTHALMOLOGY TIMES EUROPE Dr Mohamed Abou Shousha and Dr Richard Parrish II discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented realitydevices.
USING A FEMTOSECOND LASER TO CORRECT ASTIGMATISMLASER SURGERY TO CORRECT ASTIGMATISMLASER FOR ASTIGMATISMLASER SURGERY FOR ASTIGMATISM COSTASTIGMATISM LASER CORRECTIONLASER CORRECTION SURGERY FOR ASTIGMATISMLASER EYE SURGERY FOR ASTIGMATISM The management of astigmatism can be accomplished during cataract surgery. Employing femtosecond lasers improves the accuracy, safety and predictability of arcuate incisions, as well as the alignment of toric IOL placement. OPHTHALMOLOGY TIMESSPOTLIGHTCLINICALNEWSMEDIABUSINESSCONFERENCES More Americans have used and continue to use teleheath for mental health care. according to a recent online poll by the American Psychological Association.IOL
One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S. TECHNOLOGY - OPHTHALMOLOGY TIMES Mohamed Abou Shousha, MD, PhD, and Richard Parrish II, MD, discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented realitydevices.
OPHTHALMOLOGY TIMES: MAY 2021 Short learning curve, significant clinical advantages make this a comfortable addition. OPHTHALMOLOGY TIMES: MARCH 1, 2021 New option may prove to be a solution for cataract cases with unusualcorneas.
CATARACT THERAPEUTICS A recent study may indicate the need for future research to assess the relationship between pain and the anterior chamber depth. PHILLIP H. PHAN, PHD During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of theeye
MONITORING BLOOD REFLUX DURING GONIOSCOPY IN GLAUCOMAGONIOSCOPY ANGLEGONIOSCOPY EXAMGONIOSCOPY GRADING SYSTEMSGONIOSCOPY IMAGESGONIOSCOPY PROCEDURE 92020OVERUSE OF GONIOSCOPY Gonioscopy may offer a reasonable and cost-effective method to evaluate the function of the trabecular micro-bypass device post-implantation and it OPHTHALMOLOGY TIMES EUROPEOPHTHALMOLOGY TIMES EUROPE Dr Mohamed Abou Shousha and Dr Richard Parrish II discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented realitydevices.
USING A FEMTOSECOND LASER TO CORRECT ASTIGMATISMLASER SURGERY TO CORRECT ASTIGMATISMLASER FOR ASTIGMATISMLASER SURGERY FOR ASTIGMATISM COSTASTIGMATISM LASER CORRECTIONLASER CORRECTION SURGERY FOR ASTIGMATISMLASER EYE SURGERY FOR ASTIGMATISM The management of astigmatism can be accomplished during cataract surgery. Employing femtosecond lasers improves the accuracy, safety and predictability of arcuate incisions, as well as the alignment of toric IOL placement. TECHNOLOGY - OPHTHALMOLOGY TIMES Mohamed Abou Shousha, MD, PhD, and Richard Parrish II, MD, discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented realitydevices.
DIGITAL EDITION
© 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
INSIGHTS - OPHTHALMOLOGY TIMES © 2021 MJH Life Sciences and Ophthalmology Times. All rightsreserved.
REFRACTIVE - OPHTHALMOLOGY TIMES One surgeon shares the early results of his experience using the new TECNIS Eyhance and TECNIS Eyhance Toric II IOLs in performing the first post-FDA-approved cases in the U.S. GLAUCOMA - OPHTHALMOLOGY TIMES Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, offers an update on optimization and surgical modifications of newer glaucoma surgeries in preop and postop settings. 2019 OPHTHALMOLOGY TIMES RESEARCH SCHOLAR HONOREE PROGRAM Neesurg Mehta, MD Resident New York Eye and Ear Infirmary of Mount Sinai New York, NY . Chirag M. Shah, MD, MPH Resident University of California, Irvine Irvine, CA . Guneet Singh Sodhi, MD Resident Eastern Virginia Medical School Norfolk, VA . Matthew Starr, MD Residency Graduate Mayo Clinic Rochester, MN First Year Vitreoretinal Fellow Mid Atlantic Retina Wills Eye Hospital Philadelphia, PA JOANNAH VAUGHAN, MBA Regular vision screening assessments in early childhood have been shown to reduce the risk of persistent amblyopia at 7 years of age by more than half, according to YAG-SHOTS IN IOLS: SAFE OR DANGEROUS? Poorly focused YAG shots lead irrevocably to a permanent defect in the IOL material and thus to possible effects on the quality of vision with straylight or glare. In a recent study, the differing amounts of damage that Nd:YAG causes in a range of hydrophilic and MGD CARE PARADIGM SHIFTS WITH NEW TREATMENT DEVICES Reviewed by Takashi Itokawa, PhD, and Yuichi Hori, MD. The standard treatment for meibomian gland dysfunction (MGD) is application of warm compresses to the eye, with the goal of increasing the blood flow andtemperature.
PRESERVATIVE-FREE TAFLUPROST/TIMOLOL LOWERS IOP WELL A fixed-dose tafluprost and timolol combination eye drop led to significant reductions in intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) and ocular hypertension (OHT) in a safety and efficacy study, demonstrating its benefit in patients intolerant to, or insufficiently controlled on, prostaglandin analogue (PGA) monotherapy or topical beta-receptor blockers. Skip to main contentĂ
* Login
* Register
* Login
* Register
Enter your keywords Search* Topics
* Refractive
* Cataract
* Glaucoma
* Cornea
* Retina
* Practice Mgmt.
* OTE
* Job Board
__
SUBSCRIBE: Print
/ Digital
/ eNewsletter
COVID-19: Latest updates, coverage on the coronavirus With issues surrounding COVID-19, the coronavirus, grabbing headlines across the country and around the globe, ophthalmologists must understand the risks to be informed and positioned to provide quality care for their patients.Click here
to follow _Ophthalmology Times'_Ÿ ongoing coverage on the impact of the novel virus not only in ophthalmology, but the healthcare field as a whole.RECENT CONTENT
COVID-19: ADAPTING PATIENT SERVICES DURING A PANDEMICMarch 20, 2020
* Alex Delaney-Gesing _Ophthalmology TimesÂź _Chief Medical Editor Peter J. COMPANIES UNVEIL CUSTOMER INITIATIVES TO COMBAT COVID-19 CRISISMarch 20, 2020
* David Hutton
As the COVID-19 pandemic continues to escalate in the United States and across the globe, companies have announced a series of initiatives, programs, and products designed to support customers, ophthalmologists and patients. SUSTAINED-RELEASE IMPLANT OFFERS LONG-TERM IOP CONTROL, PRESERVEDVISUAL FUNCTION
March 20, 2020
* Lynda Charters
_This article was reviewed by Felipe Medeiros, MD, PhD_ COVID-19: OPHTHALMOLOGISTS' PERSPECTIVEMarch 19, 2020
* Alex Delaney-Gesing Uday Devgan, MD, FACS, FRCS, shares the latest updates from his private practice in Los Angeles, where all elective patient cases have been canceled and only urgent cases are being carried out. AAO: NEW RECOMMENDATIONS TO EYEMDS FOR URGENT, NONURGENT CARE AMIDCOVID-19
March 19, 2020
* Sheryl Stevenson
The American Academy of Ophthalmology (AAO) strongly recommends that all ophthalmologists provide only urgent or emergent patient care given the current coronavirus pandemic situation. PROCEDURES SET A NEW HORIZON IN REFRACTIVE SURGERYMarch 19, 2020
* Robert Pinelli, MD _Special to _Ophthalmology TimesÂź DISPOSABLE EYE PATCH FILLS NICHE FOR IMPROVED OCCLUSION OPTIONMarch 18, 2020
* Cheryl Guttman Krader, BS, Pharm A disposable and adjustable eye patch (MASK-it Eye Patch) is a novel alternative to traditional modalities for monocular occlusion that offers advantages for both patients and practices, said office administrator Barbara Masket. IMPROVING LASIK OUTCOMES WITH BIOMECHANICAL ANALYSISMarch 18, 2020
* Lynda Charters
_This article was reviewed by William J. Dupps Jr., MD, PhD_ COVID-19 TRAVEL UPDATE: ASCRS 2020 CANCELLEDMarch 17, 2020
* David Hutton
The American Society of Cataract and Refractive Surgery (ASCRS) has cancelled its annual meeting, scheduled for May 15-19 in Boston.CAN WE HACK AGING?
March 17, 2020
* Tim B. McLaughlin, MD A FEW YEARS BACK, I read with interest an editorial by Peter J. Browse more articles RESOURCE TOPICS RIGHTRAIL* Resource Topics
* Partner Content
* Dry Eye Awareness
* Ocular Surface Disease* Wet AMD
* IOL Advances
* Therapeutic Cataract & Refractive Topography-GuidedLASIK Planning: Taking Your Outcomesto the NextLevel
Shifting The Paradigm for Retinal Disease Management Video on CATALYSÂź Laser System presented by Johnson & Johnson Video on WHITESTAR SIGNATUREÂź PRO System by Johnson & JohnsonCME Activities
CURRENT ISSUE
Mar 20, 2020 Vol 45 No 5Digital Edition
*
*
*
* Column 1
* Home
* About Us
* Contact Us
* Column 2
* Editorial Info
* Editorial Board
* Column 3
* Advertising Info
* Reprints
* Advertising Terms
* Column 4
* Terms of Use
* Privacy Policy
* Do Not Sell My Personal Information © UBM 2020, All rights reserved. Reproduction in whole or in part is prohibited. We've noticed that you're using an ad blocker Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn offyour ad blocker.
It's off now Dismiss How do I disable my ad blocker?â
How to disable your ad blocker for our site: Adblock / Adblock Plus * Click on the AdBlock / AdBlock Plus icon on the top right of yourbrowser.
* Click âDonât run on pages on this domain.â OR âEnabled onthis site.â
* Close this help box and click "It's off now". Firefox Tracking Prevention * If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar. * Close this help box and click "It's off now".Ghostery
* Click the Ghostery icon on your browser. * In Ghostery versions < 6.0 click âWhitelist site.â in version 6.0 click âTrust site.â * Close this help box and click "It's off now". uBlock / uBlock Origin * Click the uBlock / uBlock Origin icon on your browser. * Click the âpowerâ button in the menu that appears to whitelistthe current website
* Close this help box and click "It's off now".Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0